| Stock:
|
OrthoLogic Corporation |
| |
|
| Ticker
Symbol: |
OLGC - Nasdaq -
Medical Equipment & Supplies |
| |
|
| Buy: |
5.00 to 5.50 |
| |
|
| Sell: |
9.00
+ |
| |
|
| Info: |
OrthoLogic Corporation develops,
manufactures and markets proprietary,
technologically advanced orthopedic products and
packaged services for the orthopedic healthcare
market, including bone growth stimulation devices
and continuous passive motion devices.
OrthoLogic's products are designed to enhance the
healing of diseased, damaged, degenerated or
recently repaired musculoskeletal tissue. One of
the Company's products, the OL1000, is a
portable, non-invasive, physician-prescribed
electromagnetic field bone growth stimulator
designed for patients with a nonunion fracture of
certain long bones. Another product, Spinalogic,
is a portable, non-invasive, electromagnetic
field bone growth stimulator that enhances the
healing process as an adjunct to spinal fusion
surgery. |
| |
|
| Financial
Info: |
For the fiscal year ended 12/31/01,
revenues fell 31% to $62.4 million while net loss
decreased 58% to $13.1 million. |
| |
|
| Key
Ratios: |
Current
Ratio: 6.79; Total Debt/Equity: 0.00, P/E: N/A,
Price/Book: 4.26, Price/Sales: 2.89 |
| |
|
| Share
Info: |
There are 31.8 million shares
outstanding with 22.3 million shares in the
trading float. 36 Institutions own
approximately 46.4 % of the shares outstanding.
There have been no insiders
buying or selling in the last six months.
As of 1/8/2002, there were 233,000 shares short.
 Net Institutional Selling
: N/A : prior to latest quarter. |
| |
|
| Articles: |
OrthoLogic Gets FDA OK For
Chrysalin Trial |
| |
|
| |
OrthoLogic Reports Strong
Quarterly Profit |
